Vaccinex, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.
Vaccinex stock last closed at $4.80, down 0.83% from the previous day, and has decreased 94.78% in one year. It has underperformed other stocks in the Biotechnology industry by 0.68 percentage points. Vaccinex stock is currently +8.3% from its 52-week low of $4.43, and -95.24% from its 52-week high of $100.80.
At the moment, there are 1.23M shares of VCNX outstanding. The market capitalization of VCNX is $5.91M. In the past 24 hours, 11,069 VCNX shares were traded.
You will need a brokerage account to access the NASDAQ market and buy VCNX stock.
We believe that eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro today.
Open eToro AccountNow that you've selected the best brokerage, you'll need to fill out some personal info so you are able to invest in VCNX stock today.
Now that you've finished signing up on one of the most highly reviewed stock apps, you can securely and quickly fund your account:
Check out the video below if you need help depositing money into your investment account.
Once you have decided on the best place to buy Vaccinex stock, it's absolutely critical to evaluate their stock before you buy, so you actually wrap your head around the risk and upside.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on VCNX's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge VCNX's intrinsic value.
You can do more valuation research on VCNX's stock here.
Last year, VCNX revenue was $570.00k. During the last 5 year, VCNX's revenue has gone up by -4.67% per year. This was slower than the Biotechnology industry average of 28.98%.
Dive into VCNX's earnings and revenue performance here.
Over the past year, executives and large shareholders at VCNX have bought more shares than they have sold.
Albert Friedberg, Director of VCNX, was the latest VCNX insider to buy. They bought $799,999.20 worth of VCNX shares on Mar 28, 2024.
Get more info about who owns VCNX shares here.
No, Vaccinex doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two main options:
Hit the Open button and your broker will execute the order.
If you want additional help investing in stocks on eToro, watch the helpful video below:
Now that you own some VCNX stock, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to keep track of your VCNX stock.
To reiterate, here are the 6 steps to buy Vaccinex stock:
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your investment in Vaccinex, get started below.